Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DPTX3186 |
| Synonyms | |
| Therapy Description |
DPTX3186 is a small molecule condensate modulator (c-mod), which potentially sequesters beta-catenin to inhibit transcription and induce cancer cell death (Cancer Res (2025) 85 (8_Supplement_1): 1751). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DPTX3186 | DPTX-3186|DPTX 3186 | CTNNB1 Inhibitor 28 | DPTX3186 is a small molecule condensate modulator (c-mod), which potentially sequesters beta-catenin to inhibit transcription and induce cancer cell death (Cancer Res (2025) 85 (8_Supplement_1): 1751). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07312903 | Phase I | DPTX3186 | DPTX3186 in Wnt Pathway Activated Solid Tumors | Recruiting | USA | 0 |